B. Metzler seel. Sohn & Co. AG Buys 5,471 Shares of Colgate-Palmolive Company $CL

B. Metzler seel. Sohn & Co. AG lifted its position in shares of Colgate-Palmolive Company (NYSE:CL) by 1.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 448,798 shares of the company’s stock after buying an additional 5,471 shares during the period. B. Metzler seel. Sohn & Co. AG owned about 0.06% of Colgate-Palmolive worth $35,877,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Copia Wealth Management bought a new stake in Colgate-Palmolive in the third quarter valued at approximately $29,000. Vermillion & White Wealth Management Group LLC boosted its stake in shares of Colgate-Palmolive by 86.1% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after acquiring an additional 155 shares during the period. Cloud Capital Management LLC bought a new position in shares of Colgate-Palmolive during the 3rd quarter worth approximately $30,000. MTM Investment Management LLC acquired a new position in shares of Colgate-Palmolive during the 2nd quarter worth approximately $39,000. Finally, Louisbourg Investments Inc. raised its stake in Colgate-Palmolive by 94.7% in the 3rd quarter. Louisbourg Investments Inc. now owns 514 shares of the company’s stock valued at $41,000 after acquiring an additional 250 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $93.55 on Friday. The company has a 50 day moving average of $88.98 and a 200-day moving average of $83.05. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18. The company has a current ratio of 0.83, a quick ratio of 0.54 and a debt-to-equity ratio of 18.82. The company has a market cap of $75.41 billion, a PE ratio of 35.71, a price-to-earnings-growth ratio of 4.22 and a beta of 0.28.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.04. The business had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.Colgate-Palmolive’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the prior year, the company earned $0.91 EPS. As a group, equities research analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were paid a $0.52 dividend. The ex-dividend date of this dividend was Wednesday, January 21st. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. Colgate-Palmolive’s payout ratio is currently 79.39%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 97,843 shares of Colgate-Palmolive stock in a transaction dated Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the transaction, the chief financial officer directly owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. The trade was a 63.89% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider John Hazlin sold 20,989 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total value of $1,978,213.25. Following the completion of the sale, the insider owned 17,645 shares in the company, valued at $1,663,041.25. The trade was a 54.33% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 184,683 shares of company stock worth $17,486,693. Company insiders own 0.34% of the company’s stock.

Analyst Ratings Changes

CL has been the topic of several research analyst reports. JPMorgan Chase & Co. increased their price objective on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the company an “overweight” rating in a research report on Monday, February 2nd. Citigroup upped their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Monday, February 2nd. UBS Group raised their price objective on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research report on Wednesday, January 14th. TD Cowen restated a “buy” rating on shares of Colgate-Palmolive in a report on Monday, February 2nd. Finally, Deutsche Bank Aktiengesellschaft upped their target price on Colgate-Palmolive from $83.00 to $90.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Eleven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $94.75.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.